Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma

Clinical trial NCT01376713 · COMPLETED

Trial details

NCT number: NCT01376713
Sponsor: Medical University of Vienna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Melanoma Stage IV Melanoma

Start date: 2011-06-01
Primary completion: 2015-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.